determine the PK and safety and tolerability of ATM-AVI for the treatment of cIAIs in hospitalized adults

Trial Identifier: D4910C00009
Sponsor: AstraZeneca
Collaborator:
Clinical Trial Centre, Cologne, CTCC, Germany
Universitätsklinikum Köln, UKK, Germany
University Medical Centre Utrecht, UMCU, the Netherlands
Servicio Andaluz de Salud, SAS, Spain
Centre Hospitalier Universitaire de Limoges, CHUL, France
Institute National de la Santé et de la Recherche Médicale, INSERM, France
NCTID:: NCT02655419
Start Date: May 2016
Primary Completion Date: November 2017
Study Completion Date: November 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France Amiens Cedex 1, France, 80054
France Angoulême, France, 16959
France Clermont-ferrand, France, 63003
France Lille Cedex, France, 59037
France Limoges, France, 87042
France POITIERS, France, 86021
Germany Bonn, Germany, 53127
Germany Freiburg, Germany, 79106
Germany Köln, Germany, 50937
Germany Lübeck, Germany, 23538
Germany München, Germany, 81675
Germany Regensburg, Germany, 93053
Spain Barakaldo, Spain, 48903
Spain Barcelona, Spain, 08003
Spain Barcelona, Spain, 08035
Spain Barcelona, Spain, 08036
Spain Cordoba, Spain, 14004
Spain Palma de Mallorca, Spain, 07010
Spain Sevilla, Spain, 41009
Spain Sevilla, Spain, 41013
Spain Terrassa, Spain, 08021
Spain Zaragoza, Spain, 50009